Chemours (CC)
NYSE: CC
· Real-Time Price · USD
14.54
-0.49 (-3.26%)
At close: Aug 20, 2025, 12:17 PM
Chemours Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -420M | 30M | 86M | 68M | 115M | -331M | -238M | -309M | -87M | 489M | 578M | 908M | 881M | 746M | 608M | 394M | 256M | 215M |
Depreciation & Amortization | 336M | 318M | 301M | 297M | 295M | 299M | 307M | 307M | 302M | 296M | 291M | 292M | 300M | 308M | 317M | 322M | 323M | 324M |
Stock-Based Compensation | 20M | 19M | 15M | 17M | 18M | 15M | 18M | 16M | 17M | 21M | 27M | 34M | 31M | 32M | 34M | 28M | 27M | 20M |
Other Working Capital | 299M | -654M | -760M | 57M | 33M | 1.14B | 1.05B | 200M | 114M | -242M | -396M | -70M | -92M | 1.14B | 2.72B | 2.68B | 2.7B | 2.89B |
Other Non-Cash Items | -1.01B | -721M | -762M | -736M | 280M | -2M | 7M | 4M | 48M | 5M | 10M | -113M | -143M | -104M | -89M | 35M | 24M | 36M |
Deferred Income Tax | 69M | -41M | -27M | -57M | -99M | -160M | -158M | -121M | -42M | 2M | 20M | -16M | -47M | -52M | -77M | -70M | -89M | -83M |
Change in Working Capital | 1.27B | 227M | 54M | 424M | -605M | 577M | 620M | 335M | 200M | -145M | -137M | -262M | -204M | -147M | 27M | 250M | 406M | 290M |
Operating Cash Flow | 258M | -455M | -633M | -287M | -296M | 385M | 556M | 232M | 403M | 633M | 754M | 808M | 818M | 783M | 820M | 959M | 947M | 802M |
Capital Expenditures | -312M | -342M | -360M | -386M | -396M | -381M | -370M | -302M | -288M | -292M | -307M | -323M | -318M | -323M | -277M | -247M | -227M | -221M |
Cash Acquisitions | -3M | -3M | n/a | 5M | 146M | 146M | 143M | 105M | -33M | -1M | n/a | 33.51M | 33.51M | 1.51M | 508K | 10M | 10M | 10M |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3M | -3M | -3M | -20M | -16.98M | -16.98M | -16.98M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -508K | -508K | -508K | -508K | n/a | n/a | n/a |
Other Investing Acitivies | 5M | 7M | 12M | 15M | 17M | 12M | 3M | 33M | 25M | 22M | 23M | 496M | 497M | 512M | 500M | 10.98M | 21.98M | 21.98M |
Investing Cash Flow | -310M | -338M | -353M | -376M | -243M | -233M | -229M | -164M | -296M | -271M | -284M | 203M | 209M | 187M | 220M | -226M | -205M | -199M |
Debt Repayment | 57M | 68M | 98M | -38M | 344M | 343M | 353M | 353M | -78M | -78M | -79M | -148M | -206M | -227M | -225M | -955M | -1.14B | -825M |
Common Stock Repurchased | n/a | n/a | n/a | -1M | -19M | -56M | -70M | -213M | -274M | -365M | -495M | -444M | -432M | -317M | -175M | -82M | -15M | -2M |
Dividend Paid | -124M | -148M | -148M | -149M | -148M | -149M | -149M | -149M | -151M | -151M | -154M | -158M | -160M | -163M | -164M | -164M | -164M | -164M |
Other Financial Acitivies | 60M | 53M | 52M | 97M | 28M | 34M | 18M | -20M | -17M | 23M | 43M | 54M | 36M | -5M | -3M | 638M | 657M | 653M |
Financial Cash Flow | -26M | -39M | -36M | -128M | 224M | 191M | 172M | -11M | -511M | -569M | -685M | -696M | -762M | -707M | -560M | -556M | -659M | -336M |
Net Cash Flow | -67M | -839M | -1.04B | -781M | -326M | 332M | 503M | 79M | -403M | -224M | -247M | 237M | 209M | 237M | 446M | 175M | 108M | 294M |
Free Cash Flow | -35M | -797M | -993M | -673M | -692M | 4M | 186M | -70M | 115M | 341M | 447M | 485M | 500M | 460M | 543M | 712M | 720M | 581M |